The TyG-BMI is an extension of the simpler triglyceride glucose index, a surrogate measure of insulin resistance that has gained popularity because it requires only fasting triglycerides, fasting glucose and, in this variant, body mass index. Insulin resistance, the reduced ability of cells to respond to the hormone insulin, is usually discussed in the context of type 2 diabetes and cardiovascular disease, but it also intersects with psychiatric research. Directly measuring insulin resistance with a hyperinsulinaemic glucose clamp, the laboratory gold standard, is expensive and impractical in population studies, so indices like TyG and TyG-BMI have become widely used proxies. The TyG-BMI multiplies the logarithm of the product of fasting triglycerides and glucose by BMI, producing a single number that captures both circulating lipid-glucose dynamics and overall adiposity.

The research team, led by Chunyue Guo and Bin Yang of Tianjin University’s Central Hospital together with colleagues at Tianjin institutions, analyzed data from 8,397 participants aged 45 and older. Of these, 3,902 were men and 4,495 were women, and the mean age was 59.25 years. Depressive symptoms were assessed with the 10-item Center for Epidemiological Studies Depression Scale, a brief screening instrument widely used in epidemiological surveys. Nearly three in ten participants, 28.56 percent, screened positive for depressive symptoms, a prevalence that underscores the scale of the mental health burden in this age group in China.

To probe the relationship, the investigators used two complementary statistical approaches. Multivariable logistic regression allowed them to estimate the odds of depressive symptoms across quartiles of TyG-BMI while adjusting for potential confounders. Restricted cubic spline analysis, a flexible modeling technique, let them map the shape of the association across the full range of the marker rather than forcing it into arbitrary categories. The spline results were notable for their simplicity: the relationship was linear, with a nonlinearity test yielding a p-value of 0.3274, meaning the data gave no evidence that the association curved, plateaued or reversed direction anywhere along the TyG-BMI spectrum.

The quartile analysis told a consistent story. Compared with participants in the lowest quartile of TyG-BMI, those in the second quartile had 16 percent lower odds of depressive symptoms, an adjusted odds ratio of 0.841. The third quartile showed an odds ratio of 0.726, and the highest quartile an odds ratio of 0.706, corresponding to roughly 27 to 29 percent lower odds. When TyG-BMI was treated as a continuous variable, each single-unit increase was associated with 0.4 percent lower odds of depressive symptoms, each 10-unit increase with 3.9 percent lower odds, and each one-standard-deviation increase with a 14.4 percent reduction. These effect sizes are modest at the individual level but meaningful across an entire aging population.

Importantly, the inverse association held up across prespecified subgroups. The researchers tested for interactions by sex, age and other strata and found none that reached statistical significance, with all interaction p-values above 0.05. Sensitivity analyses were conducted to check the robustness of the findings, and the overall pattern remained stable. That kind of consistency matters in observational epidemiology, where a signal that appears in one subgroup but not another often hints at confounding or chance rather than a genuine biological relationship.

What could explain a link between higher insulin resistance and fewer depressive symptoms? The authors are careful not to overinterpret, but several biological narratives are plausible. Adipose tissue and insulin signaling interact with brain pathways involving serotonin, dopamine and brain-derived neurotrophic factor, and some researchers have proposed that in certain contexts, greater energy reserves or more efficient glucose metabolism could buffer the brain against stress-related damage. Conversely, depression itself can suppress appetite and reduce body weight, meaning that some people with depressive symptoms may simply have lower TyG-BMI values because of their illness rather than the reverse. Reverse causation of this kind is a persistent hazard in cross-sectional research, where exposure and outcome are measured at the same moment in time.

There are also demographic and behavioral confounders to consider. Body mass index, diet, physical activity, chronic disease burden and socioeconomic position all shape both metabolic health and mental health, and even careful statistical adjustment cannot fully remove their influence. The study’s cross-sectional design means it captures a snapshot rather than a trajectory; it can establish that higher TyG-BMI and lower depressive symptom prevalence co-occur, but not which, if either, drives the other. The authors explicitly frame their conclusions as exploratory and call for prospective cohort studies that follow participants over time, measuring TyG-BMI before the onset of depressive symptoms, to test whether the association survives temporal ordering.

Despite these caveats, the findings add to a growing and sometimes contradictory literature on metabolic markers and late-life depression. Previous studies using the simpler TyG index and related insulin resistance surrogates in other populations, including analyses of the United States National Health and Nutrition Examination Survey, have reported associations in varying directions, reflecting differences in population age structure, adiposity distributions, dietary patterns and how depression was measured. The Chinese context is particularly important because the country is aging rapidly, and the CHARLS cohort offers nationally representative sampling of community-dwelling adults, with ethics approval from Peking University’s Biomedical Ethics Committee and written informed consent from all participants.

For clinicians and public health researchers, the practical takeaway is not that raising insulin resistance would protect mental health, a claim the data cannot support. Rather, the study highlights TyG-BMI as a cheap, calculable marker that may help stratify risk or illuminate metabolic pathways relevant to mood disorders in aging populations. Fasting triglycerides and glucose are measured routinely in blood panels, and BMI requires only height and weight, so the index could be computed at virtually no additional cost in existing cohorts and clinical records worldwide. If prospective studies confirm and clarify the relationship, the TyG-BMI could become a useful thread in the broader effort to untangle how metabolic and mental health intertwine in the second half of life.

Subject of Research: Association between the triglyceride glucose-body mass index, an insulin resistance surrogate, and depressive symptoms in middle-aged and older Chinese adults

Article Title: Associations between triglyceride glucose-body mass index and depressive symptoms among middle-aged and older adults

Article References: Guo, C., Song, C., Zhao, J., & Yang, B. (2026). Associations between triglyceride glucose-body mass index and depressive symptoms among middle-aged and older adults. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08651-4

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08651-4

Keywords: TyG-BMI, insulin resistance, depressive symptoms, CHARLS, CES-D-10, middle-aged adults, older adults, cross-sectional study, logistic regression, restricted cubic spline, BMC Psychiatry, China